Clinical Trials Logo

Recurrent Small Cell Lung Cancer clinical trials

View clinical trials related to Recurrent Small Cell Lung Cancer.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT05162196 Not yet recruiting - Clinical trials for Recurrent Small Cell Lung Cancer

The Efficacy and Safety of Radiotherapy Plus Niraparib and Toripalimab in Patients With Recurrent Small Cell Lung Cancer

Start date: June 2022
Phase: Phase 2
Study type: Interventional

This is a prospective, multicenter, open-label study to observe the efficacy and safety of combination with radiotherapy, niraparib and toripalimab in patients With recurrent small cell lung cancer(SCLC).